Skip to main content
. 2021 Nov 28;13(12):2028. doi: 10.3390/pharmaceutics13122028

Table 1.

Antibacterial effect of semisynthetic pleuromutilins based on Minimal Inhibitory Concentration [28] of active compounds (MIC: mg/L) (ATCC: American Type Culture Collection, MRSA/MSSA: methicillin resistant/sensitive S. aureus, VanA and VanB: vancomycin resistant phenotypes.)

Bacterial Strains 1 10j 10k 11h 3 14j 14k 15h
Bacillus subtilis ATCC 6633 16 32 4 32 0.5 16 256 512
Staphylococcus aureus MSSA ATCC 29213 4 16 8 16 0.5 16 512 512
Staphylococcus aureus MRSA ATCC 33591 2 4 4 4 0.5 32 512 256
Staphylococcus epidermidis ATCC 35984 biofilm 1 2 0.5 2 0.5 16 512 128
Staphylococcus epidermidis mecA 4 16 8 16 0.5 16 512 256
Enterococcus faecalis ATCC 29212 64 256 32 256 64 64 512 512
Enterococcus faecalis 15376 VanA 128 256 64 128 1 16 512 256
Enterococcus faecium VanA 38276 urine 128 128 128 128 1 2 256 256
Enterococcus faecium VanA 25192 bloodculture 128 128 128 128 2 2 512 256
Enterococcus faecium VanA 3452 drain 2 2 2 2 1 2 256 512
Enterococcus faecium VanA 24581 wound 128 128 128 128 1 1 512 512
Enterococcus faecalis ATCC 51299 VanB 128 256 32 256 64 64 256 256